In diabetic nephropathy mice models, Nrf2 knockout attenuates DKD progression through the downregulation of its target genes including angiotensinogen, Sglt2, scavenger receptor CD36, and fatty-acid-binding protein 4 [9]. This evidence concerns the gene FABP4 and diabetic kidney disease.